Pathophysiology of Covid-19 and host centric approaches in Ayurveda

Rastogi, 2022, COVID-19 pandemic: a pragmatic plan for ayurveda intervention, J Ayurveda Integr Med, 13, 100312, 10.1016/j.jaim.2020.04.002 Luke, 2012, Systems science methods in public health: dynamics, networks, and agents, Annu Rev Publ Health, 33, 357, 10.1146/annurev-publhealth-031210-101222 Bhushan, 2020, Ayurveda rasayana in prophylaxis of Covid 19, Curr Sci, 118, 1158 Tillu, 2020, Public health approach of ayurveda and Yoga for COVID-19 prophylaxis, J Altern Compl Med, 26, 360, 10.1089/acm.2020.0129 Gousseff, 2020, Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?, J Infect, 81, 816 Patwardhan, 2014, Bridging Ayurveda with evidence-based scientific approaches in medicine, EPMA J, 5, 19, 10.1186/1878-5085-5-19 Ram Manohar, 2012, Accounts of pathogenic organisms in the early texts of ayurveda, Indian J Hist Sci, 47, 545 2007 Moriyama, 2020, Seasonality of respiratory viral infections, Annu Rev Virol, 7, 10.1146/annurev-virology-012420-022445 Garbino, 2006, A prospective hospital-based study of the clinical Impact of non–severe acute respiratory syndrome (Non-SARS)–Related human coronavirus infection, Clin Infect Dis, 43, 1009, 10.1086/507898 2007 Bahl, 2020, Airborne or droplet precautions for health Workers treating coronavirus disease 2019?, J Infect Dis, 10.1093/infdis/jiaa189 P R. No Title Sims, 2005, Severe acute respiratory syndrome coronavirus infection of human ciliated airway Epithelia: role of ciliated cells in viral Spread in the conducting airways of the lungs, J Virol, 79, 15511, 10.1128/JVI.79.24.15511-15524.2005 Verdecchia, 2020, The pivotal link between ACE2 deficiency and SARS-CoV-2 infection, Eur J Intern Med, 76, 14, 10.1016/j.ejim.2020.04.037 Iwata-Yoshikawa, 2019, TMPRSS2 contributes to virus Spread and Immunopathology in the airways of murine models after coronavirus infection, J Virol, 93, 10.1128/JVI.01815-18 Wong, 2004, Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome, Clin Exp Immunol, 136, 95, 10.1111/j.1365-2249.2004.02415.x Yang, 2020, Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19, J Allergy Clin Immunol, 146, 119, 10.1016/j.jaci.2020.04.027 Qian, 2013, Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome–coronavirus, Am J Respir Cell Mol Biol, 48, 742, 10.1165/rcmb.2012-0339OC Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir Med, 8, 420, 10.1016/S2213-2600(20)30076-X Tian, 2020, Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies, Mod Pathol, 33, 1007, 10.1038/s41379-020-0536-x Tse, 2004, Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS), J Clin Pathol, 57, 260, 10.1136/jcp.2003.013276 2014 2001, Vol. 2 2007 2002 Panja, 2011, A comprehensive outlook of Sannipata, AYU (An Int Q J Res Ayurveda), 32, 154, 10.4103/0974-8520.92541 Temgoua, 2020, Coronavirus disease 2019 (COVID-19) as a multi-systemic disease and its Impact in low- and middle-income Countries (LMICs), SN Compr Clin Med, 10.1007/s42399-020-00417-7 Henry, 2020, Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis, Intern Emerg Med, 10.1007/s11739-020-02329-9 Helms, 2020, Neurologic features in severe SARS-CoV-2 infection, N Engl J Med, 382, 2268, 10.1056/NEJMc2008597 Verity, 2020, Estimates of the severity of coronavirus disease 2019: a model-based analysis, Lancet Infect Dis, 20, 669, 10.1016/S1473-3099(20)30243-7 Liu, 2020, The science underlying COVID-19, Circulation, 142, 68, 10.1161/CIRCULATIONAHA.120.047549 Tang, 2020, Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, J Thromb Haemost, 18, 1094, 10.1111/jth.14817 Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J Thromb Haemost, 18, 844, 10.1111/jth.14768 Cheng, 2020, Kidney disease is associated with in-hospital death of patients with COVID-19, Kidney Int, 97, 829, 10.1016/j.kint.2020.03.005 Su, 2020, Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China, Kidney Int, 98, 219, 10.1016/j.kint.2020.04.003 Zhang, 2020, Liver injury in COVID-19: management and challenges, Lancet Gastroenterol Hepatol, 5, 428, 10.1016/S2468-1253(20)30057-1 Seymour, 2019, Derivation, validation, and potential treatment implications of novel clinical Phenotypes for sepsis, J Am Med Assoc, 321, 2003, 10.1001/jama.2019.5791 Mamidi, 2017, Sama Sannipata jwara- sepsis, SIRS, MODS, septic shock and delirium, Int J Complement Altern Med, 8, 10.15406/ijcam.2017.08.00257 1980 Casadevall, 2015, What is a host? Incorporating the Microbiota into the damage-response framework: table 1, Infect Immun, 83, 2, 10.1128/IAI.02627-14 2007 Mahesh, 2014, A review on balya action mentioned in Ayurveda, J Ayurveda Integr Med, 5, 80, 10.4103/0975-9476.133796 Maisch, 2020, SARS-CoV-2 as potential cause of cardiac inflammation and heart failure. Is it the virus, hyperinflammation, or MODS?, Herz, 45, 321, 10.1007/s00059-020-04925-z Peng, 2009, Virus–host interactions: from systems biology to translational research, Curr Opin Microbiol, 12, 432, 10.1016/j.mib.2009.06.003